Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and ...

Samsung Bioepis, a biosimilar drug developer under Samsung Group, said Tuesday it has received approval to sell its ...

The FDA approved a new 300 mg/2 mL dose of Celltrion’s omalizumab biosimilar, Omlyclo, for the treatment of four allergic and ...